Question special
Lead Moderator

Phil and I wanted to thank everyone for contributing to this stimulating forum. For me some of the main points include the need for more research on innovative and effective approaches to interrupt transmission, particularly in community settings, in addition to the critical importance of scaling up access to rapid drug susceptibility testing for all TB patients coupled with linkage to high quality TB care programs and strategies for LTBI treatment for DR-TB contacts. We look forward to continuing these conversations! Ruvandhi